Back to search

France· FR:65534009

EPIRUBICINE MEDAC 2 mg/ml, solution pour perfusion

A epirubicin product containing chlorhydrate d'épirubicine, registered in France by MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE (ALLEMAGNE). The same ATC class is registered in 17 of our 19 countries.

ATC L01DB03

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedEPIRUBICINE MEDAC 2 mg/ml, solution p…ATCL01DB03REGISTER NO.FR:65534009PACKS LISTED5CHECKEDSeptember 12, 2026

Where it is registered

Epirubicin is registered in 17 of 19 countries.

Countries holding a registration under ATC L01DB03 (epirubicin), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose

Epirubicin · ATC L01DB03

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of epirubicin costs, country by country.

Normalised to the WHO defined daily dose (7 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Epirubicin · price per daily dose (7 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$15.02
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE D'ÉPIRUBICINE
Manufacturer
MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE (ALLEMAGNE)
Country
France (FR)
ATC code
L01DB03
ATC class
Epirubicin
Defined daily dose
7 mg, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 5

  • cip13
    3400957246594
    1 flacon(s) en verre de 5 ml
  • cip13
    3400957246716
    1 flacon(s) en verre de 25 ml
  • cip13
    3400957246884
    1 flacon(s) en verre de 50 ml
  • cip13
    3400957246945
    1 flacon(s) en verre de 100 ml
  • cip13
    3400957247027
    1 flacon(s) en verre de 200 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

560 interactions on record for epirubicin.

Graded by severity as the source publishes them — 100 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Epirubicin · interactions on record

560 records

  • 100 severe
  • 450 moderate
  • 10 minor

Most severe, free to view

  • CimetidineA02BA01severe
  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Epirubicin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All epirubicin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Epirubicin Accord, Epirubicin Ebewe
  • Belgium · Epirubicin Ab, Epirubicin Eugia
  • Bulgaria · Епирубицин Ебеве, Еписиндан
  • Cyprus · Epirubicin Aqvida, Farmorubicin
  • Czechia · Epirubicin Accord, Epirubicin Teva
  • Germany · Bendaepi, Epi
  • Denmark · Epirubicin "medac", Epirubicin Accord
  • Estonia · Epirubicin Accord
  • Spain · Epirubicina Accord, Epirubicina Aurovitas
  • Finland · Epirubicin Accord, Epirubicin Ebewe
  • United Kingdom (Northern Ireland) · Epirubicin, Epirubicin Hydrochloride Accord Healthcare
  • Greece · Epirubicin Hydrochloride Pharmachemie, Epirubicin Viatris
  • Hungary · Epirubicin Accord, Epirubicin Sandoz
  • Ireland · Epirubicin Hydrochloride Accord Healthcare Ireland, Epirubicin Seasec Pharmaceutical
  • Iceland · Epirubicin Actavis
  • Italy · Epirubicina Ahcl, Epirubicina Hikma
  • Lithuania · Epirubicin Accord
  • Luxembourg · Epirubicin Eugia, Epirubicine Teva
  • Latvia · Epirubicin Accord
  • Malta · Epirubicin Hydrochloride Accord Healthcare
  • Netherlands · Epirubicine Hcl Pharmachemie, Epirubicine Hikma
  • Norway · Epirubicin Accord, Epirubicin Ebewe
  • Poland · Epirubicin Accord, Epirubicin Ebewe
  • Portugal · Epirrubicina Accord, Epirrubicina Adoh
  • Romania · Epirubicină Teva
  • Sweden · Epirubicin Accord, Epirubicin Ebewe
  • Slovenia · Epirubicin Ebewe, Epirubicin Teva
  • Slovakia · Epimedac, Epirubicín Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f2cbde5f-bde1-435f-b9cd-b1b2d2f47eda
GET /v1/drugs/f2cbde5f-bde1-435f-b9cd-b1b2d2f47eda?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65534009",
  "date_amm": "2008-03-17",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CHLORHYDRATE D'ÉPIRUBICINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about epirubicin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.